Topical Plaque Psoriasis Research Study (20 Weeks)

Adults aged 18-75 years old with a diagnosis of chronic plaque psoriasis and stable disease for at least 6 months, may qualify to participate. Individuals must have psoriasis involving 3-20% of their body. Mild to severe disease severity must be present at the time of study entry.

Participants will receive investigational topical medication (active study drug) or placebo. Non-medicated emollients (moisturizers) may be used on non-lesional skin during participation. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 20 weeks and involve about 7 visits to the study centre, plus 2 visits which will occur by phone.

Call the study centre near you, or register now.

Learn more about
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more